These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 29129937)
1. Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity. Pate KM; Murphy RM Isr J Chem; 2017 Jul; 57(7-8):602-612. PubMed ID: 29129937 [TBL] [Abstract][Full Text] [Related]
2. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW; Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663 [TBL] [Abstract][Full Text] [Related]
4. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
5. Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease? Ba M; Kong M; Li X; Ng KP; Rosa-Neto P; Gauthier S Transl Neurodegener; 2016; 5():20. PubMed ID: 27891223 [TBL] [Abstract][Full Text] [Related]
6. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Kumar R; Nordberg A; Darreh-Shori T Brain; 2016 Jan; 139(Pt 1):174-92. PubMed ID: 26525916 [TBL] [Abstract][Full Text] [Related]
10. Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Nakamura T; Shoji M; Harigaya Y; Watanabe M; Hosoda K; Cheung TT; Shaffer LM; Golde TE; Younkin LH; Younkin SG Ann Neurol; 1994 Dec; 36(6):903-11. PubMed ID: 7998778 [TBL] [Abstract][Full Text] [Related]
11. Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests. Borghys H; Van Broeck B; Dhuyvetter D; Jacobs T; de Waepenaert K; Erkens T; Brooks M; Thevarkunnel S; Araujo JA J Alzheimers Dis; 2017; 56(2):763-774. PubMed ID: 28035921 [TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease. Inoue K; Garner C; Ackermann BL; Oe T; Blair IA Rapid Commun Mass Spectrom; 2006; 20(5):911-8. PubMed ID: 16470704 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072 [TBL] [Abstract][Full Text] [Related]
14. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model. Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237 [TBL] [Abstract][Full Text] [Related]
16. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease. Rajasekhar K; Chakrabarti M; Govindaraju T Chem Commun (Camb); 2015 Sep; 51(70):13434-50. PubMed ID: 26247608 [TBL] [Abstract][Full Text] [Related]
17. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related]
18. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid. Braak H; Zetterberg H; Del Tredici K; Blennow K Acta Neuropathol; 2013 Nov; 126(5):631-41. PubMed ID: 23756600 [TBL] [Abstract][Full Text] [Related]
19. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease. Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767 [TBL] [Abstract][Full Text] [Related]